Boxer Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,430,004
| Closed | -$146M | – | 82 |
|
|
2023
Q2 | $146M | Buy |
1,430,004
+200,000
| +16% | +$20.4M | 6.76% | 1 |
|
|
2023
Q1 | $112M | Hold |
1,230,004
| – | – | 5.49% | 2 |
|
|
2022
Q4 | $46.7M | Sell |
1,230,004
-8,996
| -0.7% | -$342K | 2.46% | 11 |
|
|
2022
Q3 | $31.1M | Hold |
1,239,000
| – | – | 1.75% | 20 |
|
|
2022
Q2 | $37.7M | Hold |
1,239,000
| – | – | 2.38% | 15 |
|
|
2022
Q1 | $40.6M | Buy |
+1,239,000
| New | +$40.6M | 2.09% | 16 |
|
|
2019
Q1 | – | Sell |
-50,000
| Closed | -$2.81M | – | 26 |
|
|
2018
Q4 | $2.81M | Sell |
50,000
-350,000
| -88% | -$19.6M | 0.35% | 22 |
|
|
2018
Q3 | $32.7M | Buy |
400,000
+75,000
| +23% | +$6.13M | 3.63% | 11 |
|
|
2018
Q2 | $11.4M | Hold |
325,000
| – | – | 1.29% | 20 |
|
|
2018
Q1 | $6.67M | Buy |
+325,000
| New | +$6.67M | 0.71% | 23 |
|
|
2017
Q4 | – | Sell |
-200,000
| Closed | -$6.22M | – | 30 |
|
|
2017
Q3 | $6.22M | Buy |
+200,000
| New | +$6.22M | 1.42% | 16 |
|